Nusantics is an East Ventures-backed Indonesian biotechnology startup with the mission to accelerate microbial and microbiome diagnostics for ONE HEALTH application. 

Since its founding in 2019, Nusantics have been on the frontline of solving various health (disease) outbreaks and challenges, such as COVID-19 RT-PCR Test Kit, Variant Detection Kit, AirScan COVID-19 detection, PUMU gargle child-friendly PCR collection, and even RT-PCR Test Kit for “Foot & Mouth” disease in cattle, as well as CeKolam, an early detection service for shrimp diseases. Nusantics actively innovates product development related to microbiome diagnostics that inspires. 

During its journey, Nusantics was selected as one of the winner of the Healthcare category startup at the G20 Digital Innovation Network 2022, and invested by world’s leading genomics company Illumina. In the future Nusantics will continuously develop and commercialize microbiome-related diagnostic tools tailored for the highly diverse Indonesian and Asian population.

For enquiries, please contact us at [email protected].
Copyright © 2022 KrASIA. All Rights Reserved.